Detalhe da pesquisa
1.
Development of Mannosylated Lipid Nanoparticles for mRNA Cancer Vaccine with High Antigen Presentation Efficiency and Immunomodulatory Capability.
Angew Chem Int Ed Engl
; 63(13): e202318515, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320193